Skip to main content
SpringerLink
Log in
Book cover

Pathologie pp 793–804Cite as

Entzündliche Myopathien

  • Chapter

  • 5403 Accesses

Zusammenfassung

Unter den entzündlichen Erkrankungen der Skelettmuskulatur sind die infektiösen, durch Viren, Bakterien, Parasiten und andere Erreger bedingten von den in unseren Breitengraden wesentlich häufigeren, offenkundig nichtinfektiösen, im Rahmen von Autoaggressionskrankheiten oder anderen immunpathogenetischen Erkrankungen auftretenden Prozessen zu unterscheiden (Polymyositis, Einschlusskörpermyositis und Dermatomyositis; interstitielle Myositiden bei Vaskulitiden, Gefäß-Bindegewebs-Erkrankungen resp. Kollagenosen; fokale Myositis, Myositis orbitalis, eosinophile Myositis, Polymyalgia rheumatica u. a.). Außerdem sind seltene, granulomatöse Entzündungen und andere, mit entzündlichen Begleitphänomenen einhergehende Erkrankungen ungeklärter Ätiologie (proliferative Myositis) abzugrenzen, die zumindest histopathologisch wohldefiniert sind. Die Differentialdiagnose dieser entzündlichen Krankheiten ist besonders wichtig, weil viele erfolgreich zu behandeln sind. Deshalb bieten sie die häufigste Indikation zur Muskel- und/oder Nervenbiopsie.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   359.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Adams RD (1975) Diseases of muscle. A study in pathology. Harper & Row, New York

    Google Scholar 

  2. Alex O, Wiethege T, Muller KM (1998) Myositis proliferans: a pseudosarcomatous lesion in soft tissue. Pathologe 19: 308–312

    Article  PubMed  CAS  Google Scholar 

  3. Amemiya K, Granger RP, Dalakas MC (2000) Clonal restriction of T-cell receptor expression by infiltrating lymphocytes in inclusion body myositis persists over time: studies in repeated muscle biopsies [In Process Citation]. Brain 123: 2030–2039

    Article  PubMed  Google Scholar 

  4. Askanas V, Engel WK (2008) Inclusion-body myositis: muscle-fiber molecular pathology and possible pathogenic significance of its similarity to Alzheimer’s and Parkinson’s disease brains. Acta Neuropathol 116: 583–595

    Article  PubMed  Google Scholar 

  5. Askanas V, Engel WK (1998) Sporadic inclusion-body myositis and hereditary inclusion-body myopathies: current concepts of diagnosis and pathogenesis. Curr Opin Rheumatol 10: 530–542

    Article  PubMed  CAS  Google Scholar 

  6. Askanas V, Engel WK, Alvarez RB, Frangione B, Ghiso J, Vidal R (2000) Inclusion body myositis, muscle blood vessel and cardiac amyloidosis, and transthyretin Val122Ile allele. Ann Neurol 47: 544–549

    Article  PubMed  CAS  Google Scholar 

  7. Banker BQ (1975) Dermatomyostis of childhood, ultrastructural alteratious of muscle and intramuscular blood vessels. J Neuropathol Exp Neurol 34: 46–75

    Article  PubMed  CAS  Google Scholar 

  8. Bartz-Bazzanella P, Christoph R, Weiner E, Mugler M, Schroder JM, Genth E (1997) [Diffuse fasciitis after Borrelia infection – a case report]. Z Rheumatol 56: 214–221

    Article  PubMed  CAS  Google Scholar 

  9. Bartz-Bazzanella P, Genth E, Pollmann HJ, Schröder JM, Völker A (1992) Eosinophilie-Myalgia-Syndrome mit Fasziitis und interstitieller Myositis nach L-Tryptophan-Einnahme (see comments). Z Rheumatol 51: 3–13

    PubMed  CAS  Google Scholar 

  10. Baumeister SK, Todorovic S, Milic-Rasic V, Dekomien G, Lochmuller H, Walter MC (2009) Eosinophilic myositis as presenting symptom in gamma-sarcoglycanopathy. Neuromuscul Disord 19: 167–171

    Article  PubMed  Google Scholar 

  11. Bäumli HP, Mumenthaler M (1977) The perifascicular atrophy factor. An aid in the histological diagnosis of polymyositis. J Neurol 214: 129–136

    Article  PubMed  Google Scholar 

  12. Carpenter S (1996) Inclusion body myositis, a review. J Neuropathol Exp Neurol 55: 1105–1114

    Article  PubMed  CAS  Google Scholar 

  13. Carpenter S, Karpati G, Heller I, Eisen A (1978) Inclusion body myositis: a distinct variety of idiopathic inflammatory myopathy. Neurology 28: 8–17

    PubMed  CAS  Google Scholar 

  14. Chahin N, Engel AG (2008) Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM. Neurology 70: 418–424

    Article  PubMed  Google Scholar 

  15. Chou SM (1967) Myxovirus-like structures in a case of human chronic polymyositis. Science 158: 1453–1455

    Article  PubMed  CAS  Google Scholar 

  16. Cornford ME, Ho HW, Vinters HV (1992) Correlation of neuromuscular pathology in acquired immune deficiency syndrome patients with cytomegalovirus infection and zidovudine treatment. Acta Neuropathol 84: 516–529

    Article  PubMed  CAS  Google Scholar 

  17. Costa RM, Dumitrascu OM, Gordon LK (2009) Orbital myositis: diagnosis and management. Curr Allergy Asthma Rep 9: 316–323

    Article  PubMed  Google Scholar 

  18. Crum-Cianflone NF (2008) Bacterial, fungal, parasitic, and viral myositis. Clin Microbiol Rev 21: 473–494

    Article  PubMed  Google Scholar 

  19. Dalakas MC, Rakocevic G, Shatunov A, Goldfarb L, Raju R, Salajegheh M (2007) Inclusion body myositis with human immunodeficiency virus infection: four cases with clonal expansion of viral-specific T cells. Ann Neurol 61: 466–475

    Article  PubMed  CAS  Google Scholar 

  20. Davis MJ, Cilo M, Plaitakis A, Yahr MD (1976) Trichinosis: severe myopathic involvement with recovery. Neurology 26: 37–40

    PubMed  CAS  Google Scholar 

  21. Dawkins RL (1965) Experimental myositis associated with hypersensitivity to muscle. J Pathol Bacteriol 90: 619–625

    Article  PubMed  CAS  Google Scholar 

  22. De Bleecker JL, Meire VI, Van Walleghem IE, Groessens IM, Schröder JM (2001) Immunolocalization of FAS and FAS ligand in inflammatory myopathies. Acta Neuropathol (Berl) 101: 572–578

    Google Scholar 

  23. Dickoff DJ, Simpson DM, Wiley CA, Mendelson SG, Farraye J, Wolfe DE, Wachsman W (1993) HTLV-1 in acquired adult myopathy. Muscle Nerve 16: 162–165

    Article  PubMed  CAS  Google Scholar 

  24. Dieler R, Schröder JM (1990) Lacunar dilatations of intrafusal and extrafusal terminal cisternae, annulate lamellae, confronting cisternae and tubulofilamentous inclusions within the spectrum of muscle and nerve fiber changes in myotonic dystrophy. Pathol Res Pract 186: 371–382

    Article  PubMed  CAS  Google Scholar 

  25. Dimitri D, Dubourg O, Maisonobe T et al. (2008) Distal inflammatory myopathy: unusual presentation of polymyositis or new entity? Neuromuscul Disord 18: 493–500

    Article  PubMed  Google Scholar 

  26. Dubowitz V, Brooke MH (1973) Muscle biopsy: A modern approach. Saunders, London Philadelphia Toronto

    Google Scholar 

  27. Emslie-Smith AM, Engel AG (1990) Microvascular changes in early and advanced dermatomyositis: a quantitative study. Ann Neurol 27: 343–356

    Article  PubMed  CAS  Google Scholar 

  28. Fidzianska A (1973) Virus-like structures in muscle in chronic polymyositis. Acta Neuropathol 23: 23–31

    Article  PubMed  CAS  Google Scholar 

  29. Fidzianska A, Glinka Z, Kaminska A, Niebroj-Dobosz I (2008) Altered distribution of lamin and emerin in muscle nuclei of sIBM patients. Clin Neuropathol 27: 424–429

    PubMed  CAS  Google Scholar 

  30. Fischer M, Kempkes U, Haage P, Isenmann S (2009) Recurrent orbital myositis mimicking sixth nerve palsy: diagnosis with MR imaging. AJNR Am J Neuroradiol 31: 275–276

    Article  PubMed  Google Scholar 

  31. Fujii K, Moriya Y, Fujita S, Akasu T, Miyake H, Nakanishi Y, Saito T (2000) Dermatomyositis accompanied by rectal cancer: report of a case. Surg Today 30: 302–304

    Article  PubMed  CAS  Google Scholar 

  32. Fujii T, Norizuki M, Kobayashi T, Yamamoto M, Kishimoto M (2009) A case of eosinophilic orbital myositis associated with CSS. Mod Rheumatol 20: 196–199

    Google Scholar 

  33. Fukuhara N (1979) Electron microscopical demonstration of nucleic acids in virus-like particles in the skeletal muscle of a traffic accident victim. Acta Neuropathol (Berl) 47: 55–59

    Article  CAS  Google Scholar 

  34. Genth E, Kaufmann S, Schröder JM, Hartl PW (1985) Zum Krankheitsbild der juvenilen Dermatomyositis. Medwelt 36: 1302–1311

    Google Scholar 

  35. Gherardi RK, Coquet M, Cherin P et al. (2001) Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle. Brain 124: 1821–1831

    Article  PubMed  CAS  Google Scholar 

  36. Gossrau G, Gestrich B, Koch R et al. (2004) Apolipoprotein E and alpha-1-antichymotrypsin polymorphisms in sporadic inclusion body myositis. Eur Neurol 51: 215–220

    Article  PubMed  CAS  Google Scholar 

  37. Gunawardena H, Betteridge ZE, McHugh NJ (2008) Newly identified autoantibodies: relationship to idiopathic inflammatory myopathy subsets and pathogenesis. Curr Opin Rheumatol 20: 675–680

    Article  PubMed  CAS  Google Scholar 

  38. Haas DC, Arnason BG (1974) Cell-mediated immunity in polymyositis. Creatine phosphokinase release from muscle cultures. Arch Neurol 31: 192–196

    PubMed  CAS  Google Scholar 

  39. Heffner RR Jr, Armbrustmacher VW, Earle KM (1977) Focal myositis. Cancer 40: 301–306

    Article  PubMed  Google Scholar 

  40. Heffner RR Jr, Barron SA (1980) Denervating changes in focal myositis, a benign inflammatory pseudotumor. Arch Pathol Lab Med 104: 261–264

    PubMed  Google Scholar 

  41. Heffner RR Jr, Barron SA (1981) Polymyositis beginning as a focal process. Arch Neurol 38: 439–442

    PubMed  Google Scholar 

  42. Hermanns B, Molnar M, Schroder JM (2000) Peripheral neuropathy associated with hereditary and sporadic inclusion body myositis: confirmation by electron microscopy and morphometry. J Neurol Sci 179: 92–102

    Article  PubMed  CAS  Google Scholar 

  43. Hewlett RH, Brownell B (1975) Granulomatous myopathy: its relationship to sarcoidosis and polymyositis. J Neurol Neurosurg Psychiatry 38: 1090–1099

    Article  PubMed  CAS  Google Scholar 

  44. Ikezoe K, Furuya H, Arahata H, Nakagawa M, Tateishi T, Fujii N, Kira J (2009) Amyloid-beta accumulation caused by chloroquine injections precedes ER stress and autophagosome formation in rat skeletal muscle. Acta Neuropathol 117: 575–582

    Article  PubMed  CAS  Google Scholar 

  45. Isaacson G, Chan KH, Heffner RR Jr (1991) Focal myositis. A new cause for the pediatric neck mass. Arch Otolaryngol Head Neck Surg 117: 103–105

    PubMed  CAS  Google Scholar 

  46. Kakulas BA (1966) Destruction of differentiated muscle cultures by sensitised lymphoid cells. J Pathol Bacteriol 91: 495–503

    Article  PubMed  CAS  Google Scholar 

  47. Katzberg HD, Munoz DG (2010) Tubuloreticular inclusions in inclusion body myositis. Clin Neuropathol 29: 262–266

    PubMed  CAS  Google Scholar 

  48. Koffman BM, Rugiero M, Dalakas MC (1998) Immunemediated conditions and antibodies associated with sporadic inclusion body myositis. Muscle Nerve 21: 115–117

    Article  PubMed  CAS  Google Scholar 

  49. Koffman BM, Sivakumar K, Simonis T, Stroncek D, Dalakas MC (1998) HLA allele distribution distinguishes sporadic inclusion body myositis from hereditary inclusion body myopathies. J Neuroimmunol 84: 139–142

    Article  PubMed  CAS  Google Scholar 

  50. Kurup A, Yew WS, San LM, Ang B, Lim S, Tai GK (2000) Outbreak of suspected trichinosis among travelers returning from a neighboring island. J Travel Med 7: 189–193

    Article  PubMed  CAS  Google Scholar 

  51. Kusters B, van Hoeve BJ, Schelhaas HJ, Ter Laak H, van Engelen BG, Lammens M (2009) TDP-43 accumulation is common in myopathies with rimmed vacuoles. Acta Neuropathol 117: 209–211

    Article  PubMed  Google Scholar 

  52. Liang Y, Inukai A, Kuru S, Kato T, Doyu M, Sobue G (2000) The role of lymphotoxin in pathogenesis of polymyositis. Acta Neuropathol (Berl) 100: 521–527

    Article  CAS  Google Scholar 

  53. Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas M, Plotz PH, Miller FW (1991) A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 70: 360–374

    CAS  Google Scholar 

  54. Lundberg IE, Grundtman C (2008) Developments in the scientific and clinical understanding of inflammatory myopathies. Arthritis Res Ther 10: 220

    Article  PubMed  Google Scholar 

  55. Matsubara S, Shima T, Takamori M (1993) Experimental allergic myositis in SJL/J mice immunized with rabbit myosin B fraction: immunohistochemical analysis and transfer. Acta Neuropathol 85: 138–144

    Article  PubMed  CAS  Google Scholar 

  56. Miller FW, Love LA, Barbieri SA, Balow JE, Plotz PH (1990) Lymphocyte activation markers in idiopathic myositis: changes with disease activity and differences among clinical and autoantibody subgroups. Clin Exp Immunol 81: 373–379

    Article  PubMed  CAS  Google Scholar 

  57. Molnar M, Schröder JM (1998) Pleomorphic mitochondrial and different filamentous inclusions in inflammatory myopathies associated with mtDNA deletions. Acta Neuropathol (Berl) 96: 41–51

    Article  CAS  Google Scholar 

  58. Müller HD, Landeghem FK, Schmidt PF, Sommer C, Goebel HH (2009) Macrophagic myofasciitis plus (distinct types of muscular dystrophy). Neuropediatrics 40: 174–178

    Article  PubMed  Google Scholar 

  59. Nakano S, Shinde A, Fujita K, Ito H, Kusaka H (2008) Histone H1 is released from myonuclei and present in rimmed vacuoles with DNA in inclusion body myositis. Neuromuscul Disord 18: 27–33

    Article  PubMed  Google Scholar 

  60. Needham M, Hooper A, James I, van Bockxmeer F, Corbett A, Day T, Garlepp MJ, Mastaglia FL (2008) Apolipoprotein epsilon alleles in sporadic inclusion body myositis: a reappraisal. Neuromuscul Disord 18: 150–152

    Article  PubMed  Google Scholar 

  61. Oldfors A, Moslemi AR, Fyhr IM, Holme E, Larsson NG, Lindberg C (1995) Mitochondrial DNA deletions in muscle fibers in inclusion body myositis. J Neuropathol Exp Neurol 54: 581–587

    Article  PubMed  CAS  Google Scholar 

  62. Oldfors A, Moslemi AR, Jonasson L, Ohlsson M, Kollberg G, Lindberg C (2006) Mitochondrial abnormalities in inclusion-body myositis. Neurology 66: S 49–55

    CAS  Google Scholar 

  63. Peng A, Koffman BM, Malley JD, Dalakas MC (2000) Disease progression in sporadic inclusion body myositis: observations in 78 patients. Neurology 55: 296–298

    PubMed  CAS  Google Scholar 

  64. Peter HH (1991) Vasculitiden. In: Gerok W, Hartmann F, Schustger HP (eds) Klinische Immunologie. Band 9, Innere Medizin der Gegenwart. Urban & Schwarzenberg, München, S 637

    Google Scholar 

  65. Plamondon S, Dent PB (2000) Juvenile amyopathic dermatomyositis: results of a case finding descriptive survey [In Process Citation]. J Rheumatol 27: 2031–2034

    PubMed  CAS  Google Scholar 

  66. Rosenberg AE (2008) Pseudosarcomas of soft tissue. Arch Pathol Lab Med 132: 579–586

    PubMed  Google Scholar 

  67. Schröder JM (1982) Pathologie der Muskulatur. Springer, Berlin Heidelberg New York

    Book  Google Scholar 

  68. Schröder JM, Bertram M, Schnabel R, Pfaff U (1992) Nuclear and mitochondrial changes of muscle fibers in AIDS after treatment with high doses of zidovudine. Acta Neuropathol 85: 39–47

    Article  PubMed  Google Scholar 

  69. Schröder JM, Molnar M (1997) Mitochondrial abnormalities and peripheral neuropathy in inflammatory myopathy, especially inclusion body myositis. Mol Cell Biochem 174: 277–281

    Article  PubMed  Google Scholar 

  70. Shamim EA, Rider LG, Miller FW (2000) Update on the genetics of the idiopathic inflammatory myopathies. Curr Opin Rheumatol 12: 482–491

    Article  PubMed  CAS  Google Scholar 

  71. Stiller D, Katenkamp D (1975) The subcutaneous fascial analogue of myositis proliferans: electron microscopic examination of two cases and comparison with myositis ossificans localisata. Virchows Arch A Pathol Anat Histol 368: 361–371

    Article  PubMed  CAS  Google Scholar 

  72. Stumpf J, Kaduk B, Undeutsch K, Landgraf H, Gofferje H (1978) Trichinose: Epidemiology, KliniK und Diagnose. Dtsch Med Wochenschr 103: 1556–1558, 1561–1552

    Article  Google Scholar 

  73. Tsuruta Y, Furuta A, Furuta K, Yamada T, Kira J, Iwaki T (2001) Expression of the lysosome-associated membrane proteins in myopathies with rimmed vacuoles. Acta Neuropathol 101: 579–584

    PubMed  CAS  Google Scholar 

  74. Vattemi G, Nogalska A, King Engel W, D’Agostino C, Checler F, Askanas V (2009) Amyloid-beta42 is preferentially accumulated in muscle fibers of patients with sporadic inclusion-body myositis. Acta Neuropathol 117: 569–574

    Article  PubMed  CAS  Google Scholar 

  75. Weihl CC, Temiz P, Miller SE et al. (2008) TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia. J Neurol Neurosurg Psychiatry 79: 1186–1189

    Article  PubMed  CAS  Google Scholar 

  76. Wirman JA (1976) Nodular fasciitis, a lesion of myofibroblasts: an ultrastructural study. Cancer 38: 2378–2389

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut für Neuropathologie, Universitätsklinikum der Rheinisch-Westfälischen Technischen Hochschule (RWTH) Aachen, Pauwelsstraße 30, 52074, Aachen, Deutschland

    J. Michael Schröder

Authors
  1. J. Michael Schröder
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Institut für Pathologie Konsultationszentrum für Pankreas- und Endokrine Tumore, TU München, Ismaninger Straße 22, 81675, München, Deutschland

    Günter Klöppel (Werkherausgeber) (Werkherausgeber)

  2. Zentrum Pathologie und Rechtsmedizin, Medizinische Hochschule Hannover (MHH), Carl-Neuberg-Straße 1, 30625, Hannover, Deutschland

    Hans H. Kreipe (Werkherausgeber) (Werkherausgeber)

  3. Institut für Pathologie, Kliniken der Landeshauptstadt, Ludwig-Erhard-Straße 100, 65199, Wiesbaden, Deutschland

    Wolfgang Remmele (Werkherausgeber) (Werkherausgeber)

  4. Institut für Neuropathologie, Universitätsklinikum Münster, Domagkstraße 19, 48149, Münster, Deutschland

    Werner Paulus (Bandherausgeber) (Bandherausgeber)

  5. Institut für Neuropathologie, Universitätsklinikum der Rheinisch-Westfälischen Technischen Hochschule (RWTH) Aachen, Pauwelsstraße 30, 52074, Aachen, Deutschland

    J. Michael Schröder (Bandherausgeber) (Bandherausgeber)

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Schröder, J. (2012). Entzündliche Myopathien. In: Klöppel, G., Kreipe, H., Remmele, W., Paulus, W., Schröder, J. (eds) Pathologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-02324-8_37

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-02324-8_37

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-02323-1

  • Online ISBN: 978-3-642-02324-8

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation